Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16ink4a
Open accessAbstract
Cellular senescence, an irreversible proliferation arrest evoked by stresses such as oncogene activation, telomere dysfunction, or diverse genotoxic insults, has been implicated in tumor suppression and aging. Primary human fibroblasts undergoing oncogene-induced or replicative senescence are known to form senescence-associated heterochromatin foci (SAHF), nuclear DNA domains stained densely by DAPI and enriched for histone modifications including lysine9-trimethylated histone H3. While cellular senescence occurs also in premalignant human lesions, it is unclear how universal is SAHF formation among various cell types, under diverse stresses, and whether SAHF occur in vivo. Here, we report that human primary fibroblasts (BJ and MRC-5) and primary keratinocytes undergoing replicative senescence, or premature senescence induced by oncogenic H-Ras, diverse chemotherapeutics and bacterial cytolethal distending toxin, show differential capacity to form SAHF. Whereas all tested cell types formed SAHF in response to activated H-Ras, only MRC-5, but not BJ fibroblasts or keratinocytes, formed SAHF under senescence induced by etoposide, doxorubicin, hydroxyurea, bacterial intoxication or telomere attrition. In addition, DAPI-defined SAHF were detected on paraffin sections of Ras-transformed cultured fibroblasts, but not human lesions at various stages of tumorigenesis. Overall, our results indicate that unlike the widely present DNA damage response marker γH2AX, SAHF is not a common feature of cellular senescence. Whereas SAHF formation is shared by diverse cultured cell types under oncogenic stress, SAHF are cell-type-restricted under genotoxin-induced and replicative senescence. Furthermore, while the DNA/DAPI-defined SAHF formation in cultured cells parallels enhanced expression of p16(ink4a) , such 'prototypic' SAHF are not observed in tissues, including premalignant lesions, irrespective of enhanced p16(ink4a) and other features of cellular senescence.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 32 cited sources checked · 0 supported · 0 flagged
- Findingown data
The percentage of SAHF-positive cells remained unchanged during extended culture up to 250 days after oncogene transduction.
“Of note, the proportions of SAHF-positive cells did not change during extended periods of cultivation until 250 days after oncogene transduction.”
Quote in the paperNot a substantial claim - Findingown data
Lentiviral delivery of H-Ras V12 caused widespread senescence in BJ fibroblasts, MRC-5 fibroblasts, and primary keratinocytes by day 12, based on morphology, SA-β-Gal staining, and reduced BrdU incorporation.
“In time course experiments, lentiviral transduction of H-Ras V12 led in all three cell types to widespread cellular senescence by day 12 after transduction, as judged by changes in morphology, enhanced SA-β-Gal staining (Fig. 1) and grossly diminished DNA replication indicated by inhibited incorporation of BrdU (Sup.Table 1).”
Quote in the paperSubstantial claim - Findingown data
MRC-5 cells undergoing senescence showed increased p16ink4a in all six scenarios, though at different levels.
“In contrast to BJ cells, and consistent with the degree of SAHF formation, extracts of MRC-5 cells undergoing senescence showed increased p16 ink4a in all six scenarios, albeit to different levels.”
Quote in the paperSubstantial claim - Findingown data
Frozen colorectal adenoma sections showed no clear evidence of classical DNA/DAPI-defined SAHF despite variable and partly focal expression of HP1γ, H3K9Me3, and SA-β-gal activity.
“Consistent with the data obtained on paraffin sections, no clear evidence of the classical DNA/DAPI-defined SAFH was seen upon examination of these adenoma frozen sections, despite the positive variable and partly even focal, expression pattern of the heterochromatin markers HP1γ, H3K9Me3 and SA-β-gal activity (data not shown and Sup.Material reviewed in ref. 48).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [48]
Not checked in the free run.
- Findingown data
The ability to form senescence-associated heterochromatin foci closely correlated with increased levels of p16ink4a in this study.
“the close correlation of the ability to form SAHF and the increased level of p16 ink4a”
Quote in the paperNot a substantial claim
- Findingown data
Paraffin sections of Ras-transformed BJ fibroblasts still showed DAPI-defined SAHF, though at a somewhat lower frequency than cells grown on coverslips.
“As can be seen from the examples of Ras-transformed BJ fibroblasts, immunohistochemical examination of paraffin sections still revealed the DNA/DAPI-defined SAHF in such specimens (Fig. 5A), albeit at somewhat lower frequency compared to senescent BJ cells grown and analyzed directly on coverslips (Fig. 1).”
Quote in the paperSubstantial claim - Findingown data
No SAHF formation was observed on tissue sections of normal epithelial tissues, adenomas, or carcinomas.
“In contrast to sections from paraffin embedded Ras-transformed BJ cells, no SAHF formation was observed on tissue sections of normal epithelial tissues, adenomas or carcinomas (Fig. 5B and data not shown).”
Quote in the paperSubstantial claim - Findingown data
The differential SAHF formation was not changed even when keratinocyte experiments were extended to day 21.
“This differential SAHF formation was not altered even when the experiments were prolonged until day 21 of keratinocytes (Fig. 4A and C and data not shown)”
Quote in the paperNot a substantial claim - Findingown data
Elevated γH2AX was observed in all three cell types studied under senescence induced by each of the six stimuli.
“we did find elevated γH2AX in all three cell types, and under senescence induced by all six stimuli studied here”
Quote in the paperNot a substantial claim - Findingown data
The proportion of SAHF-positive cells among drug-induced senescent MRC-5 cells was lower, about 20%, than among oncogene-induced senescent MRC-5 cells.
“Overall, the proportion of SAHF-positive cells among the drug-induced MRC-5 senescent cells was lower (approx.20%) than in oncogene-induced MRC-5 senescent cells, despite a similar overall senescent phenotype was seen in settings with distinct senescenceinducing stimuli (Figs. 2 and 3, Sup.Table 1 and Sup.Fig. 1).”
Quote in the paperSubstantial claim - Findingown data
Intermediate p16ink4a levels in the other four senescent scenarios corresponded with the relative proportions of cells with DNA/DAPI-defined SAHF.
“These results, as well as the intermediate levels found in the other four senescent scenarios, corresponded well with the relative proportions of cells featuring DNA/DAPI-defined SAHF among the total senescent cell population.”
Quote in the paperSubstantial claim - Findingown data
In MRC-5 cells, hydroxyurea and etoposide induced SAHF more strongly than doxorubicin, even though doxorubicin caused robust cell cycle arrest and DNA damage.
“Among the three chemotherapeutics used, HU and ET were more potent inducers of SAHF in MRC-5 cells than DOXO, despite the fact that DOXO evoked robust cell cycle arrest and DNA damage, as monitored by BrDU incorporation and γH2AX, respectively (Sup.Table 1).”
Quote in the paperSubstantial claim - Findingcitation
Some human fibroblast strains, represented by MRC-5, form SAHF during oncogene-induced and replicative senescence.
“On one hand, we confirm and extend the findings 4,38-40 that some strains of human fibroblasts, here represented by MRC-5 cells, form SAHF during oncogene-induced as well as replicative senescence.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [4]
Not checked in the free run.
- cites [38]
Not checked in the free run.
- cites [39]
Not checked in the free run.
- cites [40]
Not checked in the free run.
- Findingown data
Each of the three chemotherapeutic agents produced robust senescence phenotypes by day 12 in all three cell types.
“Each of the agents induced robust senescence phenotypes by day 12 of drug exposure, in all three cell types (see Sup. Fig. 1 for SA-β-Gal staining and Sup.Table 1 for BrdU incorporation).”
Quote in the paperSubstantial claim - Findingown data
All tested cell types formed SAHF in response to activated H-Ras.
“Whereas all tested cell types formed SAHF in response to activated H-Ras, only MRC-5, but not BJ fibroblasts or keratinocytes, formed SAHF under senescence induced by etoposide, doxorubicin, hydroxyurea, bacterial intoxication or telomere attrition.”
Quote in the paperSubstantial claim - Findingown data
BJ cells followed for an additional 150 days after reaching replicative senescence still showed no SAHF.
“To further validate the apparent differential ability to form SAHF under conditions of replicative senescence between MRC-5 and BJ fibroblasts, the latter cells were observed for additional 150 days after reaching their replicative senescence, still with no evidence of SAHF formation (data not shown).”
Quote in the paperSubstantial claim - Findingown data
Under most senescence-inducing stimuli, including chemotherapeutic drugs, bacterial intoxication, and replicative senescence, SAHF are absent in BJ fibroblasts and normal keratinocytes.
“More importantly, we show that under senescence induced by most stimuli, including several chemotherapeutic drugs, bacterial intoxication and replicative senescence, SAHF are absent in two of the three cell types used here, the BJ fibroblasts and normal keratinocytes.”
Quote in the paperSubstantial claim - Findingown data
In MRC-5 and BJ fibroblasts undergoing senescence from each of six stimuli, p16ink4a protein abundance correlated perfectly with SAHF formation.
“Indeed, biochemical examination of p16 ink4a protein abundance in the two fibroblast strains, MRC-5 and BJ undergoing senescence induced by each of the six stimuli used in our present study, showed a perfect correlation between the observed SAHF formation and the enhanced level of p16 ink4a (Fig. 6).”
Quote in the paperSubstantial claim - Findingown data
Oncogenic stress robustly induces p16ink4a, even in cells like BJ that fail to induce p16ink4a when senescence is triggered by non-oncogenic stimuli.
“One striking observation, emerging from earlier studies and corroborated by our present findings, is the robust induction of p16 ink4a in response to oncogenic stress, even in cells such as BJ that do not respond by p16 ink4a induction when undergoing senescence triggered by non-oncogenic stimuli.”
Quote in the paperSubstantial claim - Interpretationown data
Analyses of human tissues in this study indicate that it is not feasible to identify senescent cells in situ using DAPI-defined senescence-associated heterochromatin foci.
“This notion is further supported by our analyses of human tissues, suggesting that identification of senescent cells in situ through the DAPI-defined SAFH is not feasible.”
Quote in the paperSubstantial claim - Interpretationown data
The heterochromatin domains seen in human tissues appear distinct from the classical DNA/DAPI-defined SAHF seen in cultured senescent cells.
“Thus, while our data on immunofluorescence patterns of the H3K9Me3 and HP1γ markers in human tissues are consistent with previous reports on generally enhanced heterochromatinization in tumors, the observed heterochromatin domains appear to be distinct from the classical DNA/DAPI-defined SAHF observed in cell culture models undergoing senescence.”
Quote in the paperSubstantial claim - Interpretationown data
Unlike the widely present DNA damage response marker γH2AX, SAHF is not a common feature of cellular senescence.
“overall, our results indicate that unlike the widely present DNA damage response marker γH2AX, SAHF is not a common feature of cellular senescence.”
Quote in the paperSubstantial claim - Premisecitation
Constitutive DNA damage signaling is a mechanism common to all major types of cellular senescence.
“the mechanism that appears to be shared by all major types of senescence is the constitutive DNA damage signaling, often documented by the positivity of γH2AX.[13][14][15][16]48,[50][51][52]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [13]
Not checked in the free run.
- cites [14]
Not checked in the free run.
- cites [15]
Not checked in the free run.
- Interpretationreasoning
Because the keratinocytes were pooled from several donors, rare individual genetic variation or clonal selection is unlikely to explain their lack of classical SAHF.
“The latter cells are a mixed population of keratinocytes pooled from several donors, thereby excluding that any rare individual genetic variation or clonal selection events might account for the observed lack of 'classical' SAHF.”
Quote in the paperSubstantial claim - Interpretationown data
The p16ink4a results are consistent with the proposed causal role of the p16ink4a-pRb pathway in SAHF formation.
“These results are consistent with the proposed causal role of the p16 ink4a -pRb pathway in SAHF formation, and their significance is further discussed below.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [4]
Not checked in the free run.
- cites [38]
Not checked in the free run.
- Rests on an assumption: p16ink4a protein abundance reflects activation of the p16ink4a-pRb pathway in the cells studied.
- Interpretationown data
SAHF may not be a reliable common marker for identifying cells undergoing senescence.
“cell types, a more 'translational' implication of our present work is that SAFH may not represent a reliable common marker to identify cells undergoing senescence.”
Quote in the paperSubstantial claim - Premisecitation
The p16ink4a-pRb pathway appears to be required for SAHF formation.
“The p16 ink4a -pRB pathway appears to be required for SAHF formation, 4,38 and functionally SAHF have been implicated in transcriptional silencing of proliferationpromoting genes.4”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [4]
Not checked in the free run.
- cites [38]
Not checked in the free run.
- Interpretationown data
The finding of elevated γH2AX across cell types and stimuli further supports the common involvement of DNA damage response signaling and checkpoints in cellular senescence.
“an observation that further supports the common involvement of DDR signaling and checkpoints in cellular senescence.”
Quote in the paperSubstantial claim - Interpretationown data
The present findings are consistent with p16ink4a playing a causal role in the formation of senescence-associated heterochromatin foci.
“Our present findings are consistent with the proposed causal role of p16 ink4a in SAHF formation, 4”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4]
Not checked in the free run.
- Interpretationcitation
Elevated p16ink4a alone may be dispensable for the induction of senescence.
“it is evident that elevated p16 ink4a per se may be dispensable for induction of senescence, as documented by only partial correlation of heterochromatinization and p16 ink4a levels in human premalignant lesions, 48 and here for example for the BJ fibroblasts senescent in response to various chemotherapeutics or bacterial intoxication.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [48]
Not checked in the free run.
- Premisecitation
Ectopic overexpression of p16ink4a can induce the formation of senescence-associated heterochromatin foci in certain cellular contexts.
“ectopic overexpression of p16 ink4a can induce SAHF formation in certain cellular context.4”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4]
Not checked in the free run.
- Premisecitation
BJ cells undergoing replicative senescence have been reported to have low levels of p16ink4a.
“low levels of p16 ink4a were reported for BJ cells undergoing replicative senescence.32”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32]
Not checked in the free run.
- May combine two claims. 22
- The quote only partly states this claim. 1
- Classified as probably not a substantial claim. 10
May combine two claims.
Findingown dataThe earliest SAHF were detected at day 5 in all three cell types, and MRC-5 had the highest initial percentage of positive cells.
“The first detectable SAHF appeared at day 5 in all three cell types, with the highest percentage of the initially positive cells seen in MRC-5 (Fig. 2A).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataBy day 12, the initial differences among the three cell types in the proportion of SAHF-positive cells had become minimized, with no statistically significant differences.
“The initial differences in relative proportions of SAHF-positive cells among the three cell types became minimized by day 12, however, when no statistically significant differences in percentages of SAHFpositive cells were found (Fig. 2A).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe highest p16ink4a abundance in MRC-5 occurred after Ras exposure, and the lowest after doxorubicin exposure.
“Notably, the highest and lowest abundance of p16 ink4a were found in MRC-5 senescent after Ras and doxorubicin exposure, respectively (Fig. 6A).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDrug-induced senescence was accompanied by SAHF formation only in MRC-5 cells, not in BJ cells or keratinocytes treated with any of the three drugs.
“In contrast to consistent heterochromatinization and SAHF formation during the Ras oncogene-induced senescence in all three cell types, drug-induced senescence was accompanied by SAHF formation only in MRC-5 cells, but not in BJ or keratinocytes treated with any of the three drugs (Figs. 2 and 3).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn senescent BJ cells, robust p16ink4a induction occurred only under Ras-induced senescence, the only condition with classical DNA/DAPI-defined SAHF.
“Specifically, in cell extracts of senescent BJ cells, robust induction of p16 ink4a was only apparent under Ras-induced senescence, the only condition associated with the occurrence of classical DNA/DAPI-defined SAHF in these cells.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataUnder senescence caused by etoposide, doxorubicin, hydroxyurea, bacterial intoxication, or telomere attrition, only MRC-5 formed SAHF; BJ fibroblasts and keratinocytes did not.
“Whereas all tested cell types formed SAHF in response to activated H-Ras, only MRC-5, but not BJ fibroblasts or keratinocytes, formed SAHF under senescence induced by etoposide, doxorubicin, hydroxyurea, bacterial intoxication or telomere attrition.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOld senescent MRC-5 populations had DAPI-stained SAHF foci along with other senescence features, whereas senescent BJ fibroblasts lacked SAHF.
“Interestingly, the 'old,' senescent populations of MRC-5 cells displayed DAPI-stained DNA/SAHF foci accompanying other features of senescence in contrast to lack of SAHF formation in senescent BJ fibroblasts (Fig. 4B and D) despite the fact that both strains shared other recognized features of the senescent phenotype and the fact that the BJ cells reached the senescent state after more passages in”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBJ cells reached replicative senescence after more passages in vitro than MRC-5 cells.
“despite the fact that both strains shared other recognized features of the senescent phenotype and the fact that the BJ cells reached the senescent state after more passages in vitro compared to MRC-5.”
Quote in the paperNot a substantial claimMay combine two claims. The quote only partly states this claim.
Findingown dataDAPI-defined SAHF that colocalized with H3K9Me3 and HP1γ were seen in HdCDT-exposed senescent MRC-5 cells but not in similarly treated BJ cells or keratinocytes.
“Formation of DAPI-defined SAHF that colocalized with heterochromatin markers H3K9Me3 and HP1γ was observed in HdCDT-exposed senescent MRC-5 cells but not in similarly treated BJ cells and”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSAHF have been implicated in transcriptional silencing of proliferation-promoting genes.
“functionally SAHF have been implicated in transcriptional silencing of proliferationpromoting genes.4”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationActivated Ras oncogene and bacterial intoxication are known triggers of premature senescence.
“premature senescence induced by activated Ras oncogene, 22 bacterial intoxication 42 and several genotoxic chemotherapeutics”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [22]
Not checked in the free run.
- cites [42]
Not checked in the free run.
May combine two claims.
Interpretationown dataSAHF formation is not a universal component of the senescence program and appears dispensable for multiple modes of cellular senescence in various cell types.
“First, our data strongly indicate that SAHF formation is not a universal component of the senescence program and, in fact, appears to be dispensable for multiple modes of cellular senescence, in various cell types.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataSAHF formation under several genotoxic drugs is restricted to only one of the three normal human cell types tested.
“We conclude that unlike the universal occurrence of SAHF in oncogene-induced senescence, SAHF formation is restricted to only one of the three normal human cell types undergoing senescence evoked by several genotoxic drugs.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationγH2AX and other functional markers of activated DNA damage response can be conveniently assessed on tissue sections.
“γH2AX and other functional markers of activated DDR can conveniently be assessed on tissue sections.13,48,[53][54][55]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [13]
Not checked in the free run.
- cites [48]
Not checked in the free run.
- cites [53]
Not checked in the free run.
May combine two claims.
Interpretationown dataThe capacity to form SAHF does not necessarily track the senescent state in replicative and toxin-evoked senescence, and MRC-5 cells are more prone to SAHF formation than other normal cell types including epithelial cells.
“Collectively, these experiments further support the notion that the ability to form SAHF does not necessarily correlate with the senescent state, here documented for replicative and toxinevoked senescence, and that the MRC-5 cells are more prone to SAHF formation compared to other normal cell types including epithelial cells.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationHdCDT induces cellular senescence in subpopulations of various normal and cancer-derived human cell types.
“a scenario that we recently reported to induce cellular senescence in the subpopulations of various human cell types, both normal and cancer-derived”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [42]
Not checked in the free run.
May combine two claims.
Interpretationown dataProliferating cancer cells do not form classical DNA/DAPI-defined SAHF, which are apparently distinct from H3K9Me3/HP1γ-rich heterochromatin domains.
“Furthermore, the data also show that unlike senescent, arrested cells, the proliferating cancer cells do not form the classical DNA/DAPIdefined SAHF, which are apparently distinct from the H3K9Me3/HP1γ-rich heterochromatin domains that do not necessarily reflect silencing of proliferation genes such as cyclin A, a protein highly expressed in all cell lines of our panel (data not shown).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCellular senescence in clinical specimens of premalignant human lesions is accompanied by enhanced H3K9Me3 and HP1γ heterochromatinization markers correlated with active DNA damage signaling.
“We have previously reported that cellular senescence observed in clinical specimens of premalignant human lesions is accompanied by enhanced heterochromatinization markers H3K9Me3 and HP1γ that correlated with active DNA damage signaling.48”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSeveral chemotherapeutic drugs, including etoposide, hydroxyurea, and doxorubicin, are known to induce premature senescence in human cells.
“Several chemotherapeutic drugs including etoposide, 43 hydroxyurea 44 and doxorubicin 45,46 are known to induce premature senescence in human cells.”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [43]
Not checked in the free run.
- cites [44]
Not checked in the free run.
- cites [45]
Not checked in the free run.
- cites [46]
Not checked in the free run.
May combine two claims.
Interpretationown dataSAHF formation is shared by diverse cultured cell types under oncogenic stress but is cell-type-restricted under genotoxin-induced and replicative senescence.
“Whereas SAHF formation is shared by diverse cultured cell types under oncogenic stress, SAHF are cell-type-restricted under genotoxin-induced and replicative senescence.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenDiagnoses were independently verified by two experienced pathologists according to World Health Organization classification criteria.
“The diagnoses were independently verified by two experienced pathologists according to the established criteria of classification recommended by the World Health Organization.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataAlpha-tubulin was used as a loading control to ensure equal protein loading.
“Alpha-tubulin was used as a marker to ensure equal loading.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationIn replicative senescence, arrest mediated by p16ink4a seems more robust and irreversible even when p53 is depleted, whereas arrest under low p16ink4a conditions may be partially reversible.
“the p16 ink4a -mediated senescence-associated proliferation arrest appears to be more robust and irreversible even upon depletion of p53, as compared to the possibly partially reversible arrest under p16 ink4a -low conditions, at least in replicative senescence.32”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32]
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenIdentical image acquisition parameters were used for quantitative and comparative imaging.
“For quantitative and comparative imaging, identical image acquisition parameters were used.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenAll samples were originally collected at university hospitals in Aarhus and Copenhagen under ethical approval from a local Medical Research Ethics Committee in Denmark.
“All samples were originally collected at the University hospitals in Aarhus and Copenhagen, under ethical approval received from a local Medical Research Ethics Committee in Denmark.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThe results presented are averages with 95% confidence intervals, tested by unpaired t-test, from a minimum of three independent experiments.
“The results shown are averages (with 95% confidence interval, tested by unpaired t-test) of a minimum of three independent experiments.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationcitationp16ink4a is critical for the formation of senescence-associated heterochromatin foci, robust engagement of pRb, and irreversible cell cycle arrest, although it is not essential for every mode of cellular senescence.
“The overall picture emerging is that p16 ink4a , albeit not essential for every mode of cellular senescence, is critical for the formation of SAHF, 4 robust engagement of pRb and irreversible cell cycle arrest, 62,63”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [4]
Not checked in the free run.
- cites [62]
Not checked in the free run.
- cites [63]
Not checked in the free run.
May combine two claims.
InterpretationreasoningLow p16ink4a expression shifts senescence induction toward greater reliance on the p53-p21 axis and possibly other mechanisms, likely including DNA damage checkpoints, only some of which require p53.
“It appears that in cells with low expression of p16 ink4a , senescence induction relies more on the p53-p21 axis, and possibly other mechanisms, likely including also DNA damage checkpoints, only some of which require p53.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
p16ink4a protein abundance reflects activation of the p16ink4a-pRb pathway in the cells studied.
“we argued that the observed differences might reflect variable levels of the p16 ink4a CDK inhibitor, and hence the activation of the pRb pathway, whose role in SAHF formation has been documented.4,38”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
p16 induction is robust in response to oncogenic stimuli, even in cells that undergo replicative senescence with low p16 levels.
“At the same time, p16 induction is robust in response to oncogenic stimuli, even in cells that undergo replicative senescence with low p16 levels [52].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [52]
SAHF formation is not a universal feature of senescence.
“However, SAHF formation is not a universal feature of senescence.”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
The bacterial-intoxication citation points to a drug study
MinorReference 42 is cited for a previously described mode of senescence induced by bacterial intoxication, but its listed article concerns DNA-damage-induced senescence in tumor cells.
“the most recently described senescence mode induced by bacterial intoxication, 42”
“42. te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 2002; 62:1876-83.”
Error bars are described as both confidence intervals and standard deviations
MinorThe statistics section says the results are shown with 95% confidence intervals, but the Figure 2 legend says its error bars show standard deviations. These are different measures of variability.
“The results shown are averages (with 95% confidence interval, tested by unpaired t-test) of a minimum of three independent experiments.”
“error bars represent the SD of three separate experiments.”
Holotoxin-preparation citations do not match the listed papers
MinorThe methods attribute preparation of the bacterial toxin subunits and holotoxin to references 47 and 75. The listed entries concern a tumorigenesis barrier and H2AX phosphorylation, respectively, rather than that preparation.
“Preparation of CdtA, CdtB and CdtC subunits and reconstitution of the active holotoxin (HdCDT) was previously described in references 47 and 75.”
“47. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006; 444:633-7.”
Reference 48 does not match the cited earlier study
MinorThe text attributes an earlier study of heterochromatin markers in premalignant lesions to reference 48. The listed reference 48 is instead a study of BMI-1026-induced SAHF formation by different authors.
“We have previously reported that cellular senescence observed in clinical specimens of premalignant human lesions is accompanied by enhanced heterochromatinization markers H3K9Me3 and HP1γ that correlated with active DNA damage signaling.48”
“48. Seo HJ, Park HJ, Choi HS, Hwang SY, Park JS, Seong YS. BMI-1026 treatment can induce SAHF formation by activation of Erk1/2. BMB Rep 2008; 41:523-8.”
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · see citing works
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092 · see citing works
DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139
Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., & Bonner, W. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5858 · Cited by 5,438 · see citing works
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,178 · cited 2× · see citing works
“Another important aspect of our study is the close correlation of the ability to form SAHF and the increased level of p16, a CDK inhibitor whose involvement in cellular senescence and also SAHF formation has been widely studied.(4,22,32,40,56-60) Our present findings are consistent with the proposed causal role of p16…”
ResultCellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · see citing works
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688 · see citing works
Self-citationOxidative stress shortens telomeres
von Zglinicki, T. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02110-2 · Cited by 2,524 · see citing works
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,359 · see citing works
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232 · see citing works
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009 · see citing works
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · see citing works
Self-citationChemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801 · see citing works
Reversal of human cellular senescence: roles of the p53 and p16 pathways
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg417 · Cited by 1,457 · see citing works
Herbig, U., Jobling, W. A., Chen, B. P. C., Chen, D. J., & Sedivy, J. M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00256-4 · Cited by 1,344 · see citing works
Oncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220 · see citing works
A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050 · see citing works
The Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009 · see citing works
Production and purification of lentiviral vectors
Tiscórnia, G., Singer, O., & Verma, I. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.37 · Cited by 974 · see citing works
Wajapeyee, N., Serra, R. W., Zhu, X., Mahalingam, M., & Green, M. R. (2008) · Cell · doi:10.1016/j.cell.2007.12.032 · Cited by 903 · see citing works
Zhang, R., Poustovoitov, M. V., Ye, X., Santos, H. A., Chen, W., Daganzo, S. M., Erzberger, J. P., Serebriiskii, I. G., Canutescu, A. A., Dunbrack, R. L., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2004.10.019 · Cited by 699 · see citing works
DNA damage response and cellular senescence in tissues of aging mice
Wang, C., Jurk, D., Maddick, M., Nelson, G., Martin‐Ruiz, C., & Von Zglinicki, T. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00481.x · Cited by 696 · see citing works
(2002) · PubMed · Cited by 640 · see citing works
A novel role for high-mobility group A proteins in cellular senescence and heterochromatin formation
Narita, M., Narita, M., Krizhanovsky, V., Nuñez, S., Chicas, A., Hearn, S. A., Myers, M. P., & Lowe, S. W. (2006) · Cell · doi:10.1016/j.cell.2006.05.052 · Cited by 629 · see citing works
Accumulation of senescent cells in Mitotic tissue of aging primates
Jeyapalan, J. C., Ferreira, M., Sedivy, J. M., & Herbig, U. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.008 · Cited by 571 · see citing works
p16 <sup>INK4A</sup> is a robust <i>in vivo</i> biomarker of cellular aging in human skin
Ressler, S., Bartkova, J., Niederegger, H., Bartek, J., Scharffetter‐Kochanek, K., Jansen‐Dürr, P., & Wlaschek, M. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00231.x · Cited by 557 · see citing works
(1999) · PubMed · Cited by 546 · see citing works
Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions
Ramirez, R. D., Morales, C. P., Herbert, B.-S., Rohde, J. M., Passons, C., Shay, J. W., & Wright, W. E. (2001) · Genes & Development · doi:10.1101/gad.859201 · Cited by 444 · see citing works
Human cell senescence as a DNA damage response
Zglinicki, T. V., Saretzki, G., Ladhoff, J., Fagagna, F. D. D., & Jackson, S. P. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.09.034 · Cited by 419 · see citing works
Molecular dissection of formation of senescence-associated heterochromatin foci
Zhang, R., Chen, W., & Adams, P. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02019-06 · Cited by 415 · see citing works
Growth stimulation leads to cellular senescence when the cell cycle is blocked
Demidenko, Z. N., & Blagosklonny, M. V. (2008) · Cell Cycle · doi:10.4161/cc.7.21.6919 · Cited by 377 · see citing works
Cellular senescence: putting the paradoxes in perspective
Campisi, J. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.005 · Cited by 368 · see citing works
Martin, J. A., & Buckwalter, J. A. (2003) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-200300002-00014 · Cited by 320 · see citing works
PML Is a Direct p53 Target that Modulates p53 Effector Functions
de Stanchina, E., Querido, E., Narita, M., Davuluri, R. V., Pandolfi, P. P., Ferbeyre, G., & Lowe, S. W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00062-0 · Cited by 312 · see citing works
Coppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302 · see citing works
Cellular senescence and cancer treatment
Schmitt, C. A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.005 · Cited by 254 · see citing works
Quantitative assessment of markers for cell senescence
Lawless, C., Wang, C., Jurk, D., Merz, A., Zglinicki, T. V., & Passos, J. F. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.01.018 · Cited by 240 · see citing works
Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a
Alani, R. M., Young, A. Z., & Shifflett, C. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141235398 · Cited by 227 · see citing works
γ-H2AX in Cancer Cells: A Potential Biomarker for Cancer Diagnostics, Prediction and Recurrence
Martin, O. A., & Bonner, W. M. (2006) · Cell Cycle · doi:10.4161/cc.5.24.3569 · Cited by 194 · see citing works
p16Ink4a in Melanocyte Senescence and Differentiation
Sviderskaya, E. V. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.6.446 · Cited by 177 · see citing works
Ye, X., Zerlanko, B. J., Zhang, R., Somaiah, N., Lipinski, M., Salomoni, P., & Adams, P. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01592-06 · Cited by 161 · see citing works
Bártek, J., Lukas, J., & Bártková, J. (2007) · Cell Cycle · doi:10.4161/cc.6.19.4754 · Cited by 150 · see citing works
Self-citationFrisan, T., Cortes-Bratti, X., Chaves‐Olarte, E., Stenerlöw, B., & Thelestam, M. (2003) · Cellular Microbiology · doi:10.1046/j.1462-5822.2003.00311.x · Cited by 145 · see citing works
ATM Activation in Normal Human Tissues and Testicular Cancer
Bártková, J., Bakkenist, C. J., Meyts, E. R., Skakkebæk, N. E., Sehested, M., Lukas, J., Kastan, M. B., & Bártek, J. (2005) · Cell Cycle · doi:10.4161/cc.4.6.1742 · Cited by 144 · see citing works
Self-citationMartin-Ruiz, C. M., Saretzki, G. C., Petrie, J., Ladhoff, J., Jeyapalan, J. C., Wei, W., Sedivy, J. M., & von Zglinicki, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311980200 · Cited by 135 · see citing works
Cytokine expression and signaling in drug-induced cellular senescence
Novakova, Z., Hubackova, S., Kosar, M., Janderova-Rossmeislova, L., Dobrovolna, J., Vasicova, P., Vancurova, M., Horejsi, Z., Hozak, P., Bartek, J., et al. (2010) · Oncogene · doi:10.1038/onc.2009.318 · Cited by 127 · see citing works
The DNA Damage Signaling Pathway Connects Oncogenic Stress to Cellular Senescence
Mallette, F. A., & Ferbeyre, G. (2007) · Cell Cycle · doi:10.4161/cc.6.15.4516 · Cited by 125 · see citing works
Heterochromatin and its Relationship to Cell Senescence and Cancer Therapy
Zhang, R.-G., & Adams, P. (2007) · Cell Cycle · doi:10.4161/cc.6.7.4079 · Cited by 99 · see citing works
Bacterial intoxication evokes cellular senescence with persistent DNA damage and cytokine signalling
Blažková, H., Krejcikova, K., Moudrý, P., Frisan, T., Hodny, Z., & Bartek, J. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00862.x · Cited by 99 · see citing works
Irreversibility of cellular senescence: dual roles of p16INK4a/Rb-pathway in cell cycle control
Takahashi, A., Ohtani, N., & Hara, E. (2007) · Cell Division · doi:10.1186/1747-1028-2-10 · Cited by 96 · see citing works
The Senescent Side of Tumor Suppression
Collado, M., & Serrano, M. (2005) · Cell Cycle · doi:10.4161/cc.4.12.2260 · Cited by 79 · see citing works
Mobilization and recruitment of HP1β: A bimodal response to DNA breakage
Ayoub, N., Jeyasekharan, A. D., & Venkitaraman, A. R. (2009) · Cell Cycle · doi:10.4161/cc.8.18.9486 · Cited by 76 · see citing works
Hubáčková, S., Nováková, Z., Krejčíková, K., Košař, M., Dobrovolná, J., Dušková, P., Hanzlíková, H., Vančurová, M., Baráth, P., Bártek, J., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.15.12521 · Cited by 56 · see citing works
Aging-suppressants: Cellular senescence (hyperactivation) and its pharmacologic deceleration
Blagosklonny, M. V. (2009) · Cell Cycle · doi:10.4161/cc.8.12.8815 · Cited by 45 · see citing works
Pathways of oncogene-induced senescence in human melanocytic cells
Bansal, R., & Nikiforov, M. A. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12251 · Cited by 45 · see citing works
Telomeres Limit Cancer Growth by Inducing Senescence: Long-Sought In Vivo Evidence Obtained
Sedivy, J. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.014 · Cited by 44 · see citing works
Rossmeislová, L., Nováková, Z., Dobrovolná, J., Philimonenko, V. V., Hozák, P., & Hodný, Z. (2007) · Journal of Structural Biology · doi:10.1016/j.jsb.2007.02.008 · Cited by 37 · see citing works
Induction of Transcriptionally Active Jun Proteins Regulates Drug-induced Senescence
Yogev, O., Anzi, S., Inoue, K., & Shaulian, E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602865200 · Cited by 34 · see citing works
Mistrík, M., Oplustilova, L., Lukas, J., & Bártek, J. (2009) · Cell Cycle · doi:10.4161/cc.8.16.9331 · Cited by 23 · see citing works
Self-citationBártková, J., Moudrý, P., Hodný, Z., Lukáš, J., Meyts, E. R., & Bartek, J. J. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2010.01096.x · Cited by 21 · see citing works
Self-citationChromatin: a molecular interface between cancer and aging
Cruickshanks, H. A., & Adams, P. D. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.007 · Cited by 17 · see citing works
BMI-1026 treatment can induce SAHF formation by activation of Erk1/2
Seo, H.-J., Park, H. J., Choi, H.-S., Hwang, S.-Y., Park, J., & Seong, Y. (2008) · BMB Reports · doi:10.5483/bmbrep.2008.41.7.523 · Cited by 6 · see citing works
Flagged first, then by citations
Research works printed but not linked: 18
- Narita M, Nunez S, Heard E, Lin AW, Hearn SA, Spector DL, et al. Rb-mediated heterochromatin for- mation and silencing of E2F target genes during cel- lular senescence. Cell 2003; 113:703-16.
- Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, et al. Oncogene-induced senescence relayed by an interleukin-dependent inflam- matory network. Cell 2008; 133:1019-31.
- Sedelnikova OA, Horikawa I, Zimonjic DB, Popescu NC, Bonner WM, Barrett JC. Senescing human cells and ageing mice accumulate DNA lesions with unre- pairable double-strand breaks. Nat Cell Biol 2004; 6:168-70.
- d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, et al. A DNA dam- age checkpoint response in telomere-initiated senes- cence. Nature 2003; 426:194-8.
- Gray-Schopfer VC, Cheong SC, Chong H, Chow J, Moss T, Abdel-Malek ZA, et al. Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer 2006; 95:496-505.
- Brenner AJ, Stampfer MR, Aldaz CM. Increased p16 expression with first senescence arrest in human mam- mary epithelial cells and extended growth capacity with p16 inactivation. Oncogene 1998; 17:199-205.
- Bringold F, Serrano M. Tumor suppressors and onco- genes in cellular senescence. Exp Gerontol 2000; 35:317-29.
- Halazonetis TD, Gorgoulis VG, Bartek J. An onco- gene-induced DNA damage model for cancer develop- ment. Science 2008; 319:1352-5.
- Goodarzi AA, Noon AT, Jeggo PA. The impact of het- erochromatin on DSB repair. Biochem Soc Trans 2009; 37:569-76.
- Guerra L, Teter K, Lilley BN, Stenerlow B, Holmes RK, Ploegh HL, et al. Cellular internalization of cyto- lethal distending toxin: A new end to a known pathway. Cell Microbiol 2005; 7:921-34.
- Adams PD. Remodeling of chromatin structure in senescent cells and its potential impact on tumor sup- pression and aging. Gene 2007; 397:84-93.
- Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, et al. Oncogene-induced senes- cence is a DNA damage response triggered by DNA hyper-replication. Nature 2006; 444:638-42.
- Passos JF, Saretzki G, von Zglinicki T. DNA damage in telomeres and mitochondria during cellular senes- cence: Is there a connection? Nucleic Acids Res 2007; 35:7505-13.
- Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigen- esis. Nature 2005; 436:725-30.
- Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, et al. Tumour biology: Senescence in premalignant tumours. Nature 2005; 436:642.
- Blagosklonny MV. Aging-suppressants: Cellular senes- cence (hyperactivation) and its pharmacologic decelera- tion. Cell Cycle 2009; 8:1883-7.
- Chen QM, Bartholomew JC, Campisi J, Acosta M, Reagan JD, Ames BN. Molecular analysis of H 2 O 2 - induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G 1 arrest but not cell replication. Biochem J 1998; 332:43-50.
- Lobrich M, Shibata A, Beucher A, Fisher A, Ensminger M, Goodarzi AA, et al. gammaH2AX foci analy- sis for monitoring DNA double-strand break repair: strengths, limitations and optimization. Cell Cycle 2010; 9:662-9.
Cited by
Sorted by citations
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954 · see citing works
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · see citing works
Cellular senescence and tumor suppressor gene p16
Rayess, H., Wang, M. B., & Srivatsan, E. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27316 · Cited by 825 · see citing works
The DREAM complex: master coordinator of cell cycle-dependent gene expression
Sadasivam, S., & DeCaprio, J. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3556 · Cited by 524 · see citing works
Markers of cellular senescence. Telomere shortening as a marker of cellular senescence
Bernadotte, A., Mikhelson, V. M., & Spivak, I. M. (2016) · Aging · doi:10.18632/aging.100871 · Cited by 466 · see citing works
p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes
Davalos, A. R., Kawahara, M., Malhotra, G. K., Schaum, N., Huang, J., Ved, U., Beausejour, C. M., Coppe, J.-P., Rodier, F., & Campisi, J. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201206006 · Cited by 439 · see citing works
Senescence-associated inflammatory responses: aging and cancer perspectives
Lasry, A., & Ben-Neriah, Y. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.009 · Cited by 408 · see citing works
Biomarkers of cellular senescence and skin aging
Wang, A. S., & Dreesen, O. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00247 · Cited by 404 · see citing works
Mechanisms and Regulation of Cellular Senescence
Roger, L., Tomas, F., & Gire, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313173 · Cited by 395 · see citing works
Watanabe, S., Kawamoto, S., Ohtani, N., & Hara, E. (2017) · Cancer Science · doi:10.1111/cas.13184 · Cited by 321 · see citing works
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Montalto, G., Cervello, M., Nicoletti, F., Fagone, P., Malaponte, G., Mazzarino, M. C., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.652 · Cited by 310 · see citing works
Astrocyte senescence: Evidence and significance
Cohen, J., & Torres, C. (2019) · Aging Cell · doi:10.1111/acel.12937 · Cited by 281 · see citing works
Hubackova, S., Krejcikova, K., Bartek, J., & Hodny, Z. (2012) · Aging · doi:10.18632/aging.100520 · Cited by 272 · see citing works
Swanson, E. C., Manning, B., Zhang, H., & Lawrence, J. B. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201306073 · Cited by 251 · see citing works
Characterization of novel markers of senescence and their prognostic potential in cancer
Althubiti, M., Lezina, L., Carrera, S., Jukes-Jones, R., Giblett, S. M., Antonov, A., Barlev, N., Saldanha, G. S., Pritchard, C. A., Cain, K., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.489 · Cited by 256 · see citing works
Cell Senescence: Role in Aging and Age-Related Diseases
Campisi, J., & Robert, L. (2014) · Interdisciplinary Topics in Gerontology and Geriatrics · doi:10.1159/000358899 · Cited by 240 · see citing works
Tsurumi, A., & Li, W. X. (2012) · Epigenetics · doi:10.4161/epi.20540 · Cited by 248 · see citing works
Mangerich, A., Knutson, C. G., Parry, N. M., Muthupalani, S., Ye, W., Prestwich, E. G., Liang, C., McFaline‐Figueroa, J. L., Mobley, M. W., Ge, Z., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207829109 · Cited by 243 · see citing works
Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer.
Sulli, G., Di Micco, R., & di Fagagna, F. D. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3344 · Cited by 238 · see citing works
Molecular mechanisms of renal aging
Schmitt, R., & Melk, A. (2017) · Kidney International · doi:10.1016/j.kint.2017.02.036 · Cited by 235 · see citing works
Cellular senescence: Molecular mechanisms and pathogenicity
Wei, W., & Ji, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26956 · Cited by 205 · see citing works
Zhang, D., Wang, H., & Tan, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021397 · Cited by 199 · see citing works
Techniques to induce and quantify cellular senescence
Noren Hooten, N., & Evans, M. K. (2017) · Journal of Visualized Experiments · doi:10.3791/55533 · Cited by 178 · see citing works
Astrocyte Senescence and Alzheimer’s Disease: A Review
Han, X., Zhang, T., Liu, H., Mi, Y., & Gou, X. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00148 · Cited by 177 · see citing works
Maya‐Mendoza, A., Ostráková, J., Košař, M., Hall, A., Dušková, P., Mistrík, M., Merchut‐Maya, J. M., Hodný, Z., Bártková, J., Christensen, C., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.11.001 · Cited by 170 · see citing works
Reorganization of chromosome architecture in replicative cellular senescence
Criscione, S. W., De Cecco, M., Siranosian, B., Zhang, Y., Kreiling, J. A., Sedivy, J. M., & Neretti, N. (2016) · Science Advances · doi:10.1126/sciadv.1500882 · Cited by 164 · see citing works
Tumor cell escape from therapy-induced senescence
Saleh, T., Tyutyunyk-Massey, L., Murray, G. F., Alotaibi, M. R., Kawale, A. S., Elsayed, Z., Henderson, S. C., Yakovlev, V., Elmore, L. W., Toor, A., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.12.013 · Cited by 182 · see citing works
Detection of Senescence-Associated Heterochromatin Foci (SAHF)
Aird, K. M., & Zhang, R. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-239-1_12 · Cited by 171 · see citing works
Mesenchymal Stem Cell Senescence and Rejuvenation: Current Status and Challenges
Xueke, Z., Hong, Y., Zhang, H., & Li, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00364 · Cited by 166 · see citing works
Oplustilova, L., Wolanin, K., Mistrík, M., Kořínková, G., Šimková, D., Bouchal, J., Lenobel, R., Bártková, J., Lau, A., O’Connor, M. J., et al. (2012) · Cell Cycle · doi:10.4161/cc.22026 · Cited by 164 · see citing works
Self-citationKovatcheva, M., Liu, D. D., Dickson, M. A., Klein, M. E., O’Connor, R., Wilder, F. O., Socci, N. D., Tap, W. D., Schwartz, G. K., Singer, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3364 · Cited by 142 · see citing works
Cellular Senescence as the Causal Nexus of Aging
Bhatia‐Dey, N., Kanherkar, R. R., Stair, S. E., Makarev, E., & Csoka, A. B. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00013 · Cited by 147 · see citing works
Biomarkers to identify and isolate senescent cells
Matjusaitis, M., Chin, G., Sarnoski, E. A., & Stolzing, A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.003 · Cited by 144 · see citing works
Extracellular matrix alterations in senescent cells and their significance in tissue homeostasis
Mavrogonatou, E., Pratsinis, H., Papadopoulou, A., Karamanos, N. K., & Kletsas, D. (2019) · Matrix Biology · doi:10.1016/j.matbio.2017.10.004 · Cited by 153 · see citing works
Sécher, T., Samba‐Louaka, A., Oswald, É., & Nougayrède, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077157 · Cited by 134 · see citing works
Epigenetic Regulation of Cellular Senescence
Crouch, J. D., Shvedova, M., Thanapaul, R. J. R. S., Botchkarev, V. A., & Roh, D. S. (2022) · Cells · doi:10.3390/cells11040672 · Cited by 132 · see citing works
The Fountain of Youth by Targeting Senescent Cells?
de Keizer, P. L. J. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.11.006 · Cited by 127 · see citing works
Methods of Cellular Senescence Induction Using Oxidative Stress
Wang, Z., Wei, D., & Xiao, H. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-556-9_11 · Cited by 128 · see citing works
Chromatin structure and transposable elements in organismal aging
Wood, J. G., & Helfand, S. L. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00274 · Cited by 124 · see citing works
A kinase shRNA screen links LATS2 and the pRB tumor suppressorPreprint
Tschöp, K., Conery, A. R., Litovchick, L., DeCaprio, J. A., Settleman, J. E., Harlow, E., & Dyson, N. J. (2011) · Genes & Development · doi:10.1101/gad.2000211 · Cited by 125 · see citing works
Stressing the cell cycle in senescence and aging
Chandler, H., & Peters, G. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.07.005 · Cited by 119 · see citing works
Deterioration of nuclear morphology and architecture: A hallmark of senescence and aging
Pathak, R. U., Soujanya, M., & Mishra, R. K. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101264 · Cited by 119 · see citing works
Ubiquitin-activating enzyme UBA1 is required for cellular response to DNA damage
Moudrý, P., Lukas, C., Macůrek, L., Hanzlíková, H., Hodný, Z., Lukas, J., & Bártek, J. (2012) · Cell Cycle · doi:10.4161/cc.19978 · Cited by 120 · see citing works
Self-citationMechanisms and significance of therapy-induced and spontaneous senescence of cancer cells
Mikuła‐Pietrasik, J., Niklas, A. A., Uruski, P., Tykarski, A., & Książek, K. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03261-8 · Cited by 121 · see citing works
Leontieva, O. V., & Blagosklonny, M. V. (2013) · Cell Cycle · doi:10.4161/cc.26130 · Cited by 119 · see citing works
The Paradoxical Role of Cellular Senescence in Cancer
Yang, J., Liu, M., Hong, D., Zeng, M., & Zhang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722205 · Cited by 115 · see citing works
Are there roles for brain cell senescence in aging and neurodegenerative disorders?
Tan, F. C. C., Hutchison, E. R., Eitan, E., & Mattson, M. P. (2014) · Biogerontology · doi:10.1007/s10522-014-9532-1 · Cited by 116 · see citing works
The emerging role of senescent cells in tissue homeostasis and pathophysiology
Tominaga, K. (2015) · Pathobiology of Aging & Age-related Diseases · doi:10.3402/pba.v5.27743 · Cited by 112 · see citing works
Oncogene-induced senescence: From biology to therapy
Zhu, H., Blake, S., Kusuma, F. K., Pearson, R. B., Kang, J., & Chan, K. T. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111229 · Cited by 116 · see citing works
Dillinger, S., Straub, T., & Németh, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178821 · Cited by 111 · see citing works
NOTCH-mediated non-cell autonomous regulation of chromatin structure during senescence
Parry, A. J., Hoare, M., Bihary, D., Hänsel-Hertsch, R., Smith, S., Tomimatsu, K., Mannion, E., Smith, A., D’Santos, P., Russell, I. A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04283-9 · Cited by 102 · see citing works
Autophagy and senescence in cancer therapy
Gewirtz, D. A. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24420 · Cited by 108 · see citing works
BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence
Hayashi, Y., Hsiao, E. C., Sami, S., Lancero, M., Schlieve, C. R., Nguyen, T., Yano, K., Nagahashi, A., Ikeya, M., Matsumoto, Y., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603668113 · Cited by 102 · see citing works
Conserved senescence associated genes and pathways in primary human fibroblasts detected by RNA-seq
Marthandan, S., Baumgart, M., Priebe, S., Groth, M., Schaer, J., Kaether, C., Guthke, R., Cellerino, A., Platzer, M., Diekmann, S., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154531 · Cited by 91 · see citing works
Cellular senescence and tumor promotion: Is aging the key?
Loaiza, N., & Demaria, M. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.01.007 · Cited by 101 · see citing works
Zhang, X.-L., Liu, X.-H., Du, Z., Wei, L., Fang, H., Dong, Q., Niu, J., Li, Y.-D., Gao, J., Zhang, M. Q., et al. (2021) · Genome Research · doi:10.1101/gr.275235.121 · Cited by 90 · see citing works
Nuclear pore density controls heterochromatin reorganization during senescence
Boumendil, C., Hari, P., Olsen, K. C. F., Acosta, J. C., & Bickmore, W. A. (2019) · Genes & Development · doi:10.1101/gad.321117.118 · Cited by 89 · see citing works
Morphological and Functional Characteristic of Senescent Cancer Cells
Sikora, E., Mosieniak, G., & Śliwińska, M. A. (2016) · Current Drug Targets · doi:10.2174/1389450116666151019094724 · Cited by 100 · see citing works
Venkatachalam, G., Surana, U., & Clement, M. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx684 · Cited by 98 · see citing works
Cipriano, R., Kan, C. E., Graham, J., Danielpour, D., Stampfer, M., & Jackson, M. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015022108 · Cited by 92 · see citing works
The Histone Code of Senescence
Paluvai, H., Giorgio, E. D., & Brancolini, C. (2020) · Cells · doi:10.3390/cells9020466 · Cited by 94 · see citing works
Basic Methods of Cell Cycle Analysis
Ligasová, A., Frydrych, I., & Koberna, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043674 · Cited by 92 · see citing works
Feng, X., Feng, G., Xing, J., Shen, B., Tan, W., Huang, D. Y., Lu, X., Tao, T., Zhang, J., Li, L., et al. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1799-7 · Cited by 88 · see citing works
Coordinated control of senescence by lncRNA and a novel T-box3 co-repressor complex
Pavan Kumar, P., Emechebe, U., Smith, R. A., Franklin, S., Moore, B., Yandell, M. D., Lessnick, S. L., & Moon, A. (2014) · eLife · doi:10.7554/elife.02805 · Cited by 86 · see citing works
Nakamura, M., Ohsawa, S., & Igaki, T. (2014) · Nature Communications · doi:10.1038/ncomms6264 · Cited by 79 · see citing works
Cellular Senescence: Mechanisms and Therapeutic Potential
Liao, Z., Yeo, H. L., Wong, S. W., & Zhao, Y. X. (2021) · Biomedicines · doi:10.3390/biomedicines9121769 · Cited by 86 · see citing works
HIV-associated cellular senescence: A contributor to accelerated aging
Cohen, J., & Torres, C. A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.12.004 · Cited by 87 · see citing works
Chromatin Architectural Changes during Cellular Senescence and Aging
Sun, L., Yu, R., & Dang, W. (2018) · Genes · doi:10.3390/genes9040211 · Cited by 83 · see citing works
Autophagy role(s) in response to oncogenes and DNA replication stress
Vanzo, R., Bartkova, J., Merchut-Maya, J. M., Hall, A., Bouchal, J., Dyrskjøt, L., Frankel, L. B., Gorgoulis, V., Maya-Mendoza, A., Jäättelä, M., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0403-9 · Cited by 79 · see citing works
Consequences of Lamin B1 and Lamin B Receptor Downregulation in Senescence
Lukášová, E., Kovařı́k, A., & Kozubek, S. (2018) · Cells · doi:10.3390/cells7020011 · Cited by 82 · see citing works
α-Fucosidase as a novel convenient biomarker for cellular senescence
Hildebrand, D. G., Lehle, S., Borst, A., Haferkamp, S., Eßmann, F., & Schulze‐Osthoff, K. (2013) · Cell Cycle · doi:10.4161/cc.24944 · Cited by 79 · see citing works
The role of the dynamic epigenetic landscape in senescence: orchestrating SASP expression
Dasgupta, N., Arnold, R., Equey, A., Gandhi, A., & Adams, P. D. (2024) · npj Aging · doi:10.1038/s41514-024-00172-2 · Cited by 86 · see citing works
Chitikova, Z., Gordeev, S. A., Bykova, T. V., Zubova, S. G., Pospelov, V. A., & Pospelova, T. V. (2014) · Cell Cycle · doi:10.4161/cc.28402 · Cited by 77 · see citing works
Oxidative stress-mediated alterations in histone post-translational modifications
García‐Giménez, J. L., Garcés, C., Mateo, C. R., & Pallardó, F. V. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.02.027 · Cited by 74 · see citing works
Han, J., Yl, K., Lee, K.-W., Her, N.-G., Ha, T.-K., Yoon, S., Jeong, S.-I., Lee, J.-H., Kang, M. J., Lee, M.-G., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.33 · Cited by 73 · see citing works
Dynamic de novo heterochromatin assembly and disassembly at replication forks ensures fork stability
Gaggioli, V., Lo, C. S. Y., Reverón-Gómez, N., Jasencakova, Z., Domènech, H., Nguyen, H. N., Sidoli, S., Tvardovskiy, A., Uruci, S., Slotman, J. A., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01167-z · Cited by 71 · see citing works
Corpet, A., Olbrich, T., Gwerder, M., Fink, D., & Stucki, M. (2013) · Cell Cycle · doi:10.4161/cc.26988 · Cited by 65 · see citing works
Obesity and Cancer: A Gut Microbial Connection
Ohtani, N., Yoshimoto, S., & Hara, E. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3501 · Cited by 70 · see citing works
Wnt/β-catenin signaling in bone marrow niche
Ahmadzadeh, A., Norozi, F., Shahrabi, S., Shahjahani, M., & Saki, N. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2300-y · Cited by 71 · see citing works
Lessons from senescence: Chromatin maintenance in non-proliferating cells
Singh, T., & Adams, P. D. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.07.014 · Cited by 70 · see citing works
Loss of lamin B receptor is necessary to induce cellular senescence
Lukášová, E., Kovařı́k, A., Bačı́ková, A., Falk, M., & Kozubek, S. (2016) · Biochemical Journal · doi:10.1042/bcj20160459 · Cited by 68 · see citing works
Cakouros, D., & Gronthos, S. (2018) · Aging and Disease · doi:10.14336/ad.2017.1213 · Cited by 68 · see citing works
Kilic Eren, M., Kilincli, A., & Eren, Ö. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124837 · Cited by 68 · see citing works
Centenarian lamins: rapamycin targets in longevity
Lattanzi, G., Ortolani, M., Columbaro, M., Prencipe, S., Mattioli, E., Lanzarini, C., Maraldi, N. M., Cenni, V., Garagnani, P., Salvioli, S., et al. (2013) · Journal of Cell Science · doi:10.1242/jcs.133983 · Cited by 69 · see citing works
Bahrami, A., Bo, S., Jamialahmadi, T., & Sahebkar, A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101024 · Cited by 67 · see citing works
Anwar, T., Khosla, S., & Ramakrishna, G. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1189041 · Cited by 66 · see citing works
Epigenetic Basis of Cellular Senescence and Its Implications in Aging
Nacarelli, T., Liu, P., & Zhang, R. (2017) · Genes · doi:10.3390/genes8120343 · Cited by 63 · see citing works
Linking replication stress with heterochromatin formation
Nikolov, I., & Taddei, A. (2015) · Chromosoma · doi:10.1007/s00412-015-0545-6 · Cited by 58 · see citing works
Iwasaki, O., Tanizawa, H., Kim, K.-D., Kossenkov, A., Nacarelli, T., Tashiro, S., Majumdar, S., Showe, L. C., Zhang, R., & Noma, K.-I. (2019) · Nature Communications · doi:10.1038/s41467-019-13604-5 · Cited by 58 · see citing works
Feng, X., Xing, J., Feng, G., Huang, D. Y., Lu, X., Liu, S., Tan, W., Li, L., & Gu, Z. (2014) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2014.09.004 · Cited by 57 · see citing works
Integrated Stress Response (ISR) Pathway: Unraveling Its Role in Cellular Senescence
Kalinin, A., Zubkova, E., & Menshikov, M. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417423 · Cited by 58 · see citing works
Corpet, A., & Stucki, M. (2014) · Chromosoma · doi:10.1007/s00412-014-0469-6 · Cited by 56 · see citing works
Perrigue, P. M., Silva, M. E., Warden, C., Feng, N. L., Reid, M. A., Mota, D. J., Joseph, L. P., Tian, Y. I., Glackin, C. A., Gutova, M., et al. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0268 · Cited by 58 · see citing works
Macůrek, L., Benada, J., Müllers, E., Halim, V. A., Krejčíková, K., Burdová, K., Pecháčková, S., Hodný, Z., Lindqvist, A., Medema, R. H., et al. (2013) · Cell Cycle · doi:10.4161/cc.23057 · Cited by 55 · see citing works
Old cells, new tricks: chromatin structure in senescence
Parry, A. J., & Narita, M. (2016) · Mammalian Genome · doi:10.1007/s00335-016-9628-9 · Cited by 53 · see citing works
Stem Cell Senescence and Regenerative Paradigms
Beltrami, A. P., Cesselli, D., & Beltrami, C. A. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.262 · Cited by 54 · see citing works
An Activatable NIR Probe for the Detection and Elimination of Senescent Cells.
Yang, L., Liu, G.-P., Chen, Q., Wan, Y.-P., Liu, Z., Zhang, J., Huang, C., Xu, Z., Li, S., Lee, C.-S., et al. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c00239 · Cited by 43 · see citing works
From DNA Damage to Cancer Progression: Potential Effects of Cytolethal Distending Toxin
Lai, Y.-R., Chang, Y., Ma, J., Chiu, C., Kuo, M., & Lai, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.760451 · Cited by 52 · see citing works
MicroRNAs, Long Non-Coding RNAs, and Circular RNAs in the Redox Control of Cell Senescence
Lettieri-Barbato, D., Aquilano, K., Punziano, C., Minopoli, G., & Faraonio, R. (2022) · Antioxidants · doi:10.3390/antiox11030480 · Cited by 51 · see citing works
Oh, Y. S., Jeong, S., & Cho, G. (2015) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1393 · Cited by 51 · see citing works
- Authors
- Kosar, M., Bartkova, J., Hubackova, S., Hodny, Z., Lukas, J., & Bartek, J.
- Affiliations
- Danish Cancer Society (DK)
- Venue
- Cell Cycle
- Publisher
- Informa UK Limited
- Published
- 2011-02
- Volume
- 10
- Issue
- 3
- Pages
- 457-468
- ISSN
- 1538-4101 (ISSN-L)
- 1551-4005
- OpenAlex
- W2083176422
- Semantic Scholar
- 815d4c31d4f348034a5d35051dd2bd5e4c9b9f36
- Cited by
- 283
- References
- 61
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 8 · 2023: 14 · 2022: 13 · 2021: 20 · 2020: 17 · 2019: 15 · 2018: 17 · 2017: 21 · 2016: 29 · 2015: 27 · 2014: 23 · 2013: 30 · 2012: 27
- FWCI
- 19.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cell Cycle (publishedVersion)
- PubMed (publishedVersion)
- ASEP (submittedVersion, public-domain)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Funders
- European Commission
- National Research Foundation
- Danmarks Grundforskningsfond
- Grantová Agentura České Republiky (GAP301/10/1525, AV 0Z5039906, GA301/08/0353)
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, senescence-associated heterochromatin foci, replicative senescence, oncogene-induced senescence, p16INK4a, genotoxic stress, telomere shortening, cytolethal distending toxin, keratinocytes, fibroblasts, precancerous lesions, histone H3K9 trimethylation, tumor suppression
- MeSH terms
- Bacterial Toxins, Cell Line, DNA Damage, Heterochromatin, Humans, Genes, ras, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review